Direct-to-consumer advertising for cholesterol-lowering statin drugs might not be resonating with those who most need treatment, a study published in the Journal of General Internal Medicine found. Researchers found that adults who had seen statin ads were 16% to 20% more likely to get a diagnosis of high cholesterol and 16% to 22% more likely to be treated with a statin than adults who had not seen ads. However, people at high risk for heart trouble who had seen the ads were not more likely to be using statins than their low-risk peers.

Full Story:

Related Summaries